Sacituzumab govitecan in heavily pretreated, platinum-resistant high grade serous ovarian cancer

被引：0
|
作者：
Greenman, Michelle [1 ]
Bellone, Stefania [1 ]
Demirkiran, Cem [1 ]
Hartwich, Tobias Max Philipp [1 ]
Santin, Alessandro D. [1 ]
机构：
[1] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA
来源：
GYNECOLOGIC ONCOLOGY REPORTS | 2024年 / 54卷
关键词：
Sacituzumab govitecan; High grade serous ovarian cancer; Antibody-drug conjugate; TROP2;
D O I：
10.1016/j.gore.2024.101459
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
We thank the patient for allowing us to publish this case report. This work was supported in part by grants from NIH U01 CA 176067-01A1, the Deborah Bunn Alley Foundation, the Domenic Cicchetti Foundation, and Discovery to Cure Foundation, and the Guido Berlucchi Foundation
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Differentially expressed genes in platinum-resistant high-grade serous ovarian cancer
    Corey, Logan
    Alvero, Ayesha
    Tiwari, Nivedita
    You, Yuan
    Rattan, Ramandeep
    Kim, Seongho
    Mor, Gil
    Gogoi, Radhika
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S130 - S131
  • [2] Targeting Aurora A Kinase (AAK) in Platinum-Resistant High Grade Serous Ovarian Cancer
    Ganapathi, Ram N.
    Norris, Eric J.
    Sutker, Ashley P.
    Klotz, Kaitlin E.
    Ganapathi, Mahrukh K.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [3] Targeting aurora A kinase (AAK) in platinum-resistant high grade serous ovarian cancer (HGSOC)
    Ganapathi, Ram N.
    Norris, Eric J.
    Sutker, Ashley P.
    Soliman, Hala
    Ganapathi, Mahrukh K.
    CANCER RESEARCH, 2019, 79 (13)
  • [4] PIN1: A PROMISING TARGET FOR PLATINUM-RESISTANT HIGH GRADE SEROUS OVARIAN CANCER
    Spena, Concetta Russo
    De Stefano, Lucia
    Salis, Barbara
    Granchi, Carlotta
    El Boustani, Maguie
    Palazzolo, Stefano
    Mouawad, Nayla
    Tuccinardi, Tiziano
    Canzonieri, Vincenzo
    Caligiuri, Isabella
    Rizzolio, Flavio
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 218 - 218
  • [5] Genetic variation in platinum-sensitive and platinum-resistant high-grade serous epithelial ovarian cancer
    Castellano, Tara
    Clark, Leslie H.
    Rashid, Naim
    Bae-Jump, Victoria
    CANCER RESEARCH, 2017, 77
  • [6] Sacituzumab govitecan improves OS in heavily pretreated patients
    Peter Sidaway
    Nature Reviews Clinical Oncology, 2023, 20 : 734 - 734
  • [7] Uncovering mechanisms of response of pembrolizumab and lenvatinib for the treatment of platinum-resistant high grade serous ovarian cancer
    How, Jeffrey
    Westin, Shannon Neville
    Sims, Travis T.
    Lito, Kathryn
    Celestino, Joseph
    Rangel, Kelly M.
    Peng, Weiyi
    Wang, Linghua
    Jazaeri, Amir A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Repurposing nelfinavir for re-sensitizing platinum-resistant high grade serous ovarian cancer cells
    Forgie, Benjamin N.
    Goyeneche, Alicia A.
    Telleria, Carlos M.
    CANCER RESEARCH, 2024, 84 (05)
  • [9] Sacituzumab govitecan improves OS in heavily pretreated patients
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (11) : 734 - 734
  • [10] A platinum-resistant subtype of high-grade serous ovarian cancer identified by a network of somatic mutations.
    Shen, John P.
    Bojorquez-Gomez, Ana
    Huang, Justin
    Hofree, Matan
    Kurnit, Katie
    Klepper, Kristin
    Beckett, Alex
    Kreisberg, Jason F.
    Saenz, Cheryl C.
    Ideker, Trey
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345